0.8 ML adalimumab-bwwd 50 MG/ML Injection [Hadlima]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

0.8 ML adalimumab-bwwd 50 MG/ML Injection [Hadlima]

50 MG/ML · Injection · injection

A form of adalimumab-bwwd →

0.8 ML adalimumab-bwwd 50 MG/ML Injection [Hadlima] — Tumor necrosis factor alpha (TNF-alpha) inhibitors. Strength, form, class, interactions & more.

0.8 ML adalimumab-bwwd 50 MG/ML Injection [Hadlima]

Active ingredient

adalimumab-bwwd →

Classification

Tumor necrosis factor alpha (TNF-alpha) inhibitorsTumor Necrosis Factor Blocker

Drug interactions

Adalimumab-bwwd has several drug interactions that may increase the risk of serious infections or require monitoring of concomitant medications.

  • majorabatacept — Increased risk of serious infection
  • majoranakinra — Increased risk of serious infection
  • majorlive vaccines — Avoid use
  • moderateCYP450 substrates (e.g., warfarin, cyclosporine, theophylline) — Possible influence on drug concentration

Real-world adverse events (FAERS)

Drug Hypersensitivity2Injection Site Pain2Tachypnoea2Influenza Like Illness1Rash Pruritic1Rash Pustular1Tachycardia1Uveitis1

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.

Get started freeSee how Eleplan works →